NOVONIX Limited filings document foreign-issuer reports furnished on Form 6-K, with exhibits drawn from ASX announcements and corporate notices. The record includes disclosures on annual general meeting presentations and voting results, material-event updates, material agreements, operating and financial results, and governance matters tied to the company's battery materials business.
Capital-structure filings cover applications for quotation of ordinary fully paid securities, securities issued from option exercises or convertible-security conversions, performance rights, and director interest notices. These filings also record shareholder voting matters and formal updates relevant to NOVONIX's ADR and foreign-issuer reporting framework.
Novonix Limited, an Australia-based foreign private issuer, filed a Form 6-K for October 2025. The filing primarily forwards an attached document, Exhibit 99.1, which is an Appendix 2A Application for quotation of securities dated October 08, 2025.
The report is signed on behalf of Novonix by Chief Financial Officer Robert Long, confirming the company’s submission of this securities quotation application to the market under U.S. reporting rules.
NOVONIX Limited, a foreign private issuer based in Brisbane, Australia, submitted a Form 6-K report to the SEC for September 2025. The report forwards an ASX announcement titled “NOVONIX Achieves Critical Operational Milestone” dated September 29, 2025.
The filing is signed on behalf of the company by Chief Financial Officer Robert Long, confirming the ASX announcement as official information provided to U.S. investors.
NOVONIX Limited submitted a Form 6-K as a foreign private issuer for September 2025. The filing mainly furnishes an ASX announcement, attached as Exhibit 99.1, regarding the “Sale of Mt Dromedary Natural Graphite Project” dated September 25, 2025. The report is signed by the company’s Chief Financial Officer, Robert Long.
Novonix Limited furnished a Form 6-K as a foreign private issuer for September 2025. The report lists Exhibit 99.1, described as an Appendix 2A titled “Application for quotation of securities” dated September 25, 2025. The filing is signed by Chief Financial Officer Robert Long.